Ischemic Necrosis clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
open to eligible people ages 18-80
A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
at UC Davis
Our lead scientists for Ischemic Necrosis research studies include Oyebimpe O Adesina, MD, MS.